Characteristic of trimetazidine MR influence on the CDH course in patients with diabetes mellitus type 2
Date
2012
Authors
Stepanova, Olena
Kryuchkiov, Y.
Journal Title
Journal ISSN
Volume Title
Publisher
KNMU
Abstract
Trimetazidine MR showed high efficiency in the treatment of
patients with CDH and diabetes mellitus type 2. The research has shown that adding
trimetazidine MR (dosage 70 mg/day) to the basic therapy is advisable for tolerance
increase to the physical activity and improvement of the quality of life in patients
with CDH and diabetes mellitus type 2.
Description
Keywords
diabetes mellitus type 2, trimetazidine MR
Citation
Stepanova O. Characteristic of trimetazidine MR influence on the CDH course in patients with diabetes mellitus type 2 / O. Stepanova, Y. Kryuchkiov // 5th International Scientific Interdisciplinary Conference (ISIC) for medical students and young doctors, Kharkiv, April 25–26, 2012 : Abstract book. – Kharkiv, 2012. – P. 77–78.